Mast cell disease: Surgical and anesthetic implications

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 7, 2006, Pages 446-449

  Damodar, Sharat ^a,b   John, Colin Noel ^a   Gopalakrishnan, Gayathri ^a   Nair, Sheila ^c   Samuel, Rekha ^c   Thomas, Mathew ^b   Shetty, Devi Prasad ^a  

^a Department of Haematology ^*  (India)

^b Department of Cardiac Surgery ^*  (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Anesthesia; Mast cell disease; Surgery

Indexed keywords

HYDROCORTISONE; RANITIDINE;

ADOLESCENT; ANESTHESIA; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAST CELL; MAST CELL DISEASE; MASTOCYTOSIS; OPEN HEART SURGERY; PRIORITY JOURNAL;

ADOLESCENT; ANESTHESIA; BONE MARROW; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HEPATOMEGALY; HUMANS; LYMPHATIC DISEASES; MASTOCYTOSIS, SYSTEMIC; SPLENOMEGALY;

EID: 33746324511     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212950.12856.d4     Document Type: Article

References (14)

1. Austen KF, Boyce JA. Mast cell lineage development and phenotypic regulation. Leuk Res. 2001;25:511-518.
2. Valent P, Kiener HP. Mast cells. In: Smolen JS, Lipsky PE, eds. Targeted Therapy in Rheumatology. Vol 1. London, New York: Martin Dunitz; 2003:83-109.
3. Horny H-P, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res. 2001;25:543-551.
4. Koyamangalath Krishnan, Mastocytosis, Systemic www.emedicine.com/med/ topic1401.htm-93k.
5. Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am. 2000;14:579-623.
6. Metcalfe DD. The liver, spleen, and lymph nodes in mastocytosis. J Invest Dermatol. 1991;96:45S-46S.
7. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-625.
8. Valent P, Horny HP, Li CY, et al. Mastocytosis. In: Jaffe ES, Harris NL, Stein H, et al. eds. World Health Organization Classification of Tumours. Pathology and Genetics of tumors. Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:291-302.
9. Tefferi A, Li CY, Butterfield JH, et al. Treatment of systemic mastcell disease with cladribine. N Engl J Med. 2001;344:307-309.
10. Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, et al. Cladribine therapy for systemic mastocytosis. Blood. 2003;102:4270-4276.
11. Pardanani A, Ketterling RP, Brockman SR, et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 2003;102:3093-3096.
12. Akin C, Fumo G, Yavuz AS, et al. A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib. Blood. 2004;103:3222-3225.
13. Ricciardi L, Saitta S, Isola S, et al. Systemic mastocytosis associated with recurrent paroxysmal atrial fibrillation. Allergy. 2005;60:542.
14. Vaughan ST, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia. 1998;53:804-807.